See all treatments in the PatientsLikeMe system shared by patients just like you.
What is r(+) pramipexole?
R(+) pramipexole dihydrochloride monohydrate [R(+)PPX], an experimental neuroprotective drug, is provided in this open label extension study to ALS patients who have participated in earlier clinical protocols.
Read more...
See more information, including instructions, precautions, side effects, and interactions.
3 patients in the community are taking or have taken r(+) pramipexole.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Slow my ALS progress | 2 | 66% |
| Other | 1 | 33% |
Based on the patients currently taking r(+) pramipexole.
| 300 mg day | ||
|---|---|---|
|
2
|
||
How long current patients have been taking r(+) pramipexole or how long patients were taking r(+) pramipexole before stopping.